GenBio
Private Company
Funding information not available
Overview
Founded in 1994 (incorporated in 1998), GenBio is a private, revenue-generating diagnostics company headquartered in Salt Lake City, Utah. It has established itself as a commercial-stage player with a broad portfolio of immunoassay kits for infectious and autoimmune diseases, distributed worldwide through a specialized network. The company's strategy emphasizes rapid commercialization, custom product development for specific markets, and maintaining rigorous regulatory compliance to serve global laboratory needs.
Technology Platform
Immunoassay (primarily ELISA) development and manufacturing platform for serological detection of antibodies, leveraging licensed IP from governments and academic institutions.
Opportunities
Risk Factors
Competitive Landscape
GenBio competes in the crowded serology diagnostics market against global IVD leaders (e.g., Abbott, Roche, DiaSorin) who offer automated, high-throughput systems, as well as against numerous smaller specialty manufacturers. Its competitive edge lies in its focus on immunoassay expertise, flexibility for custom products, and a value-oriented proposition for laboratories using manual or semi-automated ELISA workflows.